The FDA approved UCB SA's UCBJF UCBJY Rystiggo (rozanolixizumab-noli) for generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AchR) or anti-muscle-specific ...
Multiple sclerosis (MS) involves the progressive loss of the protective layer of nerve fibers, myelin, and its loss, called demyelination, results in symptoms of MS. Blocking the protein receptor, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback